Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    Chosa

    MCap

    SEK57m

    Last close

    SEK0.80

    ▲ 0.20 (33.33%)

    Vection Technologies

    MCap

    AUD47m

    Last close

    AUD0.04

    ▲ 0.00 (12.90%)

    Metro Bank

    MCap

    GBP684m

    Last close

    GBP1.02

    ▲ 7.90 (8.43%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Belluscura: Edison Open House Healthcare 2022

Belluscura: Edison Open House Healthcare 2022

Belluscura is a publicly traded UK company listed on the AIM submarket of the London Stock Exchange (AIM: BELL). Belluscura focuses on developing and commercialising innovative oxygen enrichment technologies that span broad industries and therapies.

• What does Belluscura’s oxygen do and what are its advantages for patients?
• What are the opportunities for Belluscura in a market dominated by a handful of well-established players?
• Please tell more about the plans for your two new products, X-PLO₂R CX and X-PLO₂R DX.
• Tell us about the large market for these products.
• What is your intellectual property strategy and are partnerships part of the plan to add more to your patent portfolio?
• Is noise a consideration?
• When entering different markets such as wound care, how will you approach the requirement for extra development?
• Which company events should investors look out for in the coming months?

< Previous
Next >

You may also be interested in these:

Healthcare

Recce Pharmaceuticals – executive interview

TMT

VEON – executive interview with CFO Joop Brakenhoff

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free